News

20 Apr: Complete Revasc Not Superior to Culprit-Only PCI After MI

In patients with ST-elevation myocardial infarction (STEMI) and multivessel disease, fractional flow reserve (FFR)-guided complete nonculprit revascularization did not reduce death, myocardial infarction (MI) or unplanned revascularization compared with culprit lesion-only percutaneous coronary intervention (PCI). “Around half of all patients undergoing primary PCI to the culprit lesion in STEMI have multivessel disease…

Healthy diet lowers heart disease risk in breast cancer survivors, study finds

17 Apr: Healthy diet lowers heart disease risk in breast cancer survivors, study finds

Editors’ notes This article has been reviewed according to Science X’s editorial process and policies. Editors have highlighted the following attributes while ensuring the content’s credibility: fact-checked trusted source proofread by Oxford University Press Credit: Unsplash/CC0 Public Domain A new paper in JNCI Cancer Spectrum finds that following a healthy diet lowers the risk of cardiovascular

Physical activity lowers cardiovascular disease risk by reducing stress-related brain activity, study finds

15 Apr: Physical activity lowers cardiovascular disease risk by reducing stress-related brain activity, study finds

Credit: Unsplash/CC0 Public Domain New research indicates that physical activity lowers cardiovascular disease risk in part by reducing stress-related signaling in the brain. In the study, which was led by investigators at Massachusetts General Hospital (MGH), a founding member of the Mass General Brigham health care system and published in the Journal of the American

Stopping aspirin 1 month after coronary stenting significantly reduces bleeding complications in heart attack patients

08 Apr: Stopping aspirin 1 month after coronary stenting significantly reduces bleeding complications in heart attack patients

The primary efficacy endpoint of clinically-relevant bleeding, defined as BARC types 2, 3 or 5 bleeding, was assessed in the intention-to-treat population between one-month and twelve-months post-PCI in patients who were event-free after one month of ticagrelor and aspirin. Switching to ticagrelor monotherapy at one month resulted in a 55-percent reduction in the hazard of

Clinical trial: First cardiac bioimplants for treatment of myocardial infarction using umbilical cord stem cells

05 Apr: Clinical trial: First cardiac bioimplants for treatment of myocardial infarction using umbilical cord stem cells

The results of a pioneering study support the safety of the bioimplants called PeriCord, made from stem cells of the umbilical cord and pericardium from a tissue donor, which aid in the regeneration and revascularization of the affected area. The study has monitored seven interventions of this pioneering tissue engineering surgery over three years…